Pendapatan dodolan perusahaan Verona Pharma PLC (VRNA)

Verona Pharma - logo grafis emiten VRNA

Short-term expectations for Verona Pharma plc (VRNA) depend on the rollout pace of its new COPD product. The company's sales chart demonstrates current dynamics, where 0.22 serves as the base parameter value. Strong pricing power is driven by the unique mechanism of Ohtuvayre, although fierce competition with global behemoths in the inhalation niche creates significant barriers to business expansion.

VRNA - Pendapatan lan volume dodolan Verona Pharma ing rentang 04.07.2022 - 18.10.2025

Rincian analitis perusahaan Verona Pharma plc

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:Verona Pharma plc VRNA
Barang unggulan Verona Pharma plc

Investors must evaluate the asset's fundamental stability by analyzing actual cash inflows. This metric captures daily customer revenue, excluding speculative expectations and demonstrating real income. The company's execution history allows an auditor to verify the efficiency of operational management. For Verona Pharma plc (VRNA), growth in this metric confirms strong pricing power during the rollout of Ohtuvayre. Inelastic demand for the innovative drug ensures a steady cash inflow.

Pesaing wigati

HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|MENS (Jyong Biotech Limited) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ligand Pharma LGND|Pendapatan lan volume dodolan Amneal Corp AMRX|Perrigo Company PLC - Pendapatan lan volume dodolan|ALVO: Pendapatan perusahaan|liquidia.com (LQDA) - Pendapatan perusahaan|GLPG (Galapagos) - Pendapatan perusahaan|Dodolan perusahaan ANIP|Volume dodolan perusahaan MNKD (Afrezza)|Pendapatan lan volume dodolan AMPH|PCRX (Pacira BioSciences) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Pendapatan perusahaan|Aquestive Corp - Pendapatan lan volume dodolan|scpharmaceuticals.com (SCPH) - Dodolan perusahaan|TECX: Pendapatan lan volume dodolan|Tonix Pharmaceuticals - Pendapatan dodolan perusahaan|Dodolan perusahaan SXTC|EPRX: Pendapatan dodolan perusahaan|Dodolan perusahaan BHST (BioHarvest Sciences Inc.)|Pendapatan reged perusahaan Invizyne|Pendapatan perusahaan Oramed Pharmaceuticals ORMP|Pendapatan dodolan perusahaan ENTX|HYFT - Pendapatan perusahaan|Pendapatan dodolan perusahaan ABVC (ABVC BioPharma Inc.)|CPIX: Pendapatan lan volume dodolan|Quantum BioPharma Limited - Pendapatan dodolan perusahaan|FGEN (FibroGen Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Telomir Pharmaceuticals|Pendapatan lan volume dodolan RANI|SNYR (Synergy CHC Corp.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLYB (Rallybio Corp)|LEXX: Volume dodolan perusahaan|PULM - Pendapatan perusahaan|PTHL: Pendapatan perusahaan|APM (aptorumgroup.com) - Dodolan perusahaan|Lyra Therapeutics - Pendapatan dodolan perusahaan|Pendapatan perusahaan Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan YCBD|PRFX: Pendapatan tahunan perusahaan|Pendapatan perusahaan altamiratherapeutics.com CYTO|Pendapatan lan volume dodolan Lipella Pharmaceuticals Inc LIPO|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP